Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TN › Clarksville › NPI 1073049102
Clinic

Pain Institute of Nashville, PLC

Pain Institute of Nashville, PLC was paid $55K by Medicaid between Nov 2018 and May 2024, across 25 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 57% of everything it billed.

33Billing provider infoPAIN INSTITUTE OF NASHVILLE, PLC
CLARKSVILLE, TN 37043
33aNPI1073049102assigned 05/10/2017
33bProvider typePain Clinic/Center
28Total paid$55K
24GClaims61,566
24DCodes billed25
24AFirst – last monthNov 2018 – May 2024
Compared with peers

Next to other Pain Clinic/Center providers in Tennessee

Rank by total paid#6 of 10
Median peer was paid$55K
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.5K$5.0K$7.5K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,365$11.76
201911,203$6K
202010,915$12K
202119,521$12K
20229,471$11K
20237,294$10K
2024incomplete1,797$3K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 57% 15,825 9,611 $31K
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes 12% 7,510 4,533 $7K
96136 11% 6,068 3,634 $6K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3.8% 14,369 8,507 $2K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 3.8% 9,875 5,891 $2K
96138 3.6% 816 519 $2K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 3.1% 85 78 $2K
96132 2.5% 273 177 $1K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 1.6% 4,646 2,726 $859.69
96127 <1% 669 430 $324.73
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 27 18 $213.98
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity <1% 141 63 $148.34
13 more codes
96146 <1% 638 $47.73
93922 <1% 28 $33.00
95923 <1% 14 $25.75
87500 <1% 27 $16.46
87640 <1% 27 $16.46
87641 <1% 27 $16.46
96120 <1% 195 $4.02
96103 <1% 195 $2.38
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 0% 18 $0.00
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 0% 27 $0.00
81002 0% 21 $0.00
80305 0% 31 $0.00
95921 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWOOD, RON (BILLING MANAGER)
Same official

Other billing entities under WOOD, RON

Full network →
ProviderLocationPaid
Beck, Griffith, Cirillo, and Patel, P.A.Prince Frederick, MD$15K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.